Welcome to LookChem.com Sign In|Join Free
  • or
3-hydroxyadipic acid 3,6-lactone is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

60551-20-4

Post Buying Request

60551-20-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

60551-20-4 Usage

Synthesis Reference(s)

Synthetic Communications, 7, p. 125, 1977 DOI: 10.1080/00397917708050722

Check Digit Verification of cas no

The CAS Registry Mumber 60551-20-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,0,5,5 and 1 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 60551-20:
(7*6)+(6*0)+(5*5)+(4*5)+(3*1)+(2*2)+(1*0)=94
94 % 10 = 4
So 60551-20-4 is a valid CAS Registry Number.
InChI:InChI=1/C6H8O4/c7-5(8)3-4-1-2-6(9)10-4/h4H,1-3H2,(H,7,8)

60551-20-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(5-oxooxolan-2-yl)acetic acid

1.2 Other means of identification

Product number -
Other names 2-Furanacetic acid,tetrahydro-5-oxo

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:60551-20-4 SDS

60551-20-4Relevant academic research and scientific papers

PANTETHEINE DERIVATIVES AND USES THEREOF

-

Paragraph 2121, (2020/06/19)

The present disclosure relates to compounds of Formula (I), (II), or (II'): (I), (II), (II'), and pharmaceutically acceptable salts or solvates thereof. The present disclosure also relates to pharmaceutical compositions comprising the compounds and therapeutic and diagnostic uses of the compounds and pharmaceutical compositions.

METHOD FOR PRODUCING epsilon-CAPROLACTAM

-

Paragraph 0105; 0106, (2020/03/09)

The present invention is a method of producing ε-caprolactam through adipamide as an intermediate, and characteristically includes a lactamization step of reacting adipamide, formed from a material compound, with hydrogen and ammonia in the presence of a catalyst containing: a metal oxide mainly containing an oxide(s) of one or more metallic elements selected from the group consisting of metallic elements of group 5 and groups 7 to 14 in the 4th to 6th periods of the periodic table; and a metal and/or a metal compound having a hydrogenation ability. The method can increase the selectivity of ε-caprolactam.

METHOD FOR PRODUCING EPSILON-CAPROLACTAM

-

Paragraph 0060; 0061, (2017/11/29)

A method for selective production of ε-caprolactam, wherein a substance inducible from a biomass resource is used as a material; the reaction process is short; ammonium sulfate is not produced as a by-product; and production of by-products is suppressed; is disclosed. The method for producing ε-caprolactam comprises the step of reacting a particular compound inducible from a biomass resource, such as α-hydromuconic acid, 3-hydroxyadipic acid, or 3-hydroxyadipic acid-3,6-lactone, or a salt thereof with hydrogen or ammonia.

Cis, cis -Muconic acid isomerization and catalytic conversion to biobased cyclic-C6-1,4-diacid monomers

Carraher, Jack M.,Pfennig, Toni,Rao, Radhika G.,Shanks, Brent H.,Tessonnier, Jean-Philippe

, p. 3042 - 3050 (2017/07/24)

Renewable terephthalic and 1,4-cyclohexanedicarboxylic acids can be produced from biomass via muconic acid using a combination of biological and chemical processes. In this conversion scheme, cis,cis-mucononic acid is first obtained by fermentation using

METHOD FOR PREPARING 1,6-HEXANEDIOL

-

Paragraph 0183; 0184, (2016/11/14)

The invention relates to a process for preparing hexane-1,6-diol, in which a) a muconic acid starting material is provided, selected from muconic acid, esters of muconic acid, lactones of muconic acid and mixtures thereof,b) the muconic acid starting material is subjected to a reaction with hydrogen in the presence of at least one hydrogenation catalyst to hexane-1,6-diol, andc) the output from the hydrogenation in step b) is subjected to a distillative separation to obtain hexane-1,6-diol.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 60551-20-4